FDA Inspection 1245488 — Laboratorio Italiano Biochimico Farmaceutico Lisapharma SPA
The FDA completed an inspection of Laboratorio Italiano Biochimico Farmaceutico Lisapharma SPA on January 26, 2024 in Erba. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 26, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Erba (Italy)
Additional Details
Mutual Recognition Agreement (MRA)